Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Current practice and evolving concepts in septic shock resuscitation
Clinical and pathophysiological understanding of septic shock has progressed exponentially
in the previous decades, translating into a steady decrease in septic shock-related morbidity …
in the previous decades, translating into a steady decrease in septic shock-related morbidity …
Sepsis-induced myocardial dysfunction
KR Walley - Current opinion in critical care, 2018 - journals.lww.com
Sepsis-induced myocardial dysfunction is increasingly recognized as a major contributor to
outcome of septic shock. Significant strides have been made in understanding the …
outcome of septic shock. Significant strides have been made in understanding the …
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …
Infection as an under-recognized precipitant of acute heart failure: prognostic and therapeutic implications
S Bezati, M Velliou, I Ventoulis, P Simitsis… - Heart Failure …, 2023 - Springer
As the prevalence of heart failure (HF) continues to rise, prompt diagnosis and management
of various medical conditions, which may lead to HF exacerbation and result in poor patient …
of various medical conditions, which may lead to HF exacerbation and result in poor patient …
Current use of inotropes in circulatory shock
Background Treatment decisions on critically ill patients with circulatory shock lack
consensus. In an international survey, we aimed to evaluate the indications, current practice …
consensus. In an international survey, we aimed to evaluate the indications, current practice …
[HTML][HTML] Septic cardiomyopathy: A narrative review
Sepsis is a systemic inflammatory response syndrome of suspected or documented
infectious origin, whose outcome is multiorgan failure. Sepsis-induced myocardial …
infectious origin, whose outcome is multiorgan failure. Sepsis-induced myocardial …
Pathophysiology, mechanisms, and managements of tissue hypoxia
J Mallat, N Rahman, F Hamed, G Hernandez… - … Critical Care & Pain …, 2022 - Elsevier
Oxygen is needed to generate aerobic adenosine triphosphate and energy that is required
to support vital cellular functions. Oxygen delivery (DO 2) to the tissues is determined by …
to support vital cellular functions. Oxygen delivery (DO 2) to the tissues is determined by …
Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis
DH Liu, YL Ning, YY Lei, J Chen, YY Liu, XF Lin… - Scientific reports, 2021 - nature.com
Levosimendan and dobutamine are extensively used to treat sepsis-associated
cardiovascular failure in ICU. Nevertheless, the role and mechanism of levosimendan in …
cardiovascular failure in ICU. Nevertheless, the role and mechanism of levosimendan in …
Efficacy and safety of levosimendan in patients with sepsis: a systematic review and network meta-analysis
R Tan, H Guo, Z Yang, H Yang, Q Li, Q Zhu… - Frontiers in …, 2024 - frontiersin.org
Objective: We conducted a systematic review to assess the advantages and disadvantages
of levosimendan in patients with sepsis compared with placebo, milrinone, and dobutamine …
of levosimendan in patients with sepsis compared with placebo, milrinone, and dobutamine …
Sirt3 is a novel target to treat sepsis induced myocardial dysfunction by acetylated modulation of critical enzymes within cardiac tricarboxylic acid cycle
Y Xu, S Zhang, J Rong, Y Lin, L Du, Y Wang… - Pharmacological …, 2020 - Elsevier
Sepsis induced myocardial dysfunction (SIMD) results in high morbidity and mortality.
However, the effective therapeutic strategies for SIMD treatment remain limited. Sirt3 is the …
However, the effective therapeutic strategies for SIMD treatment remain limited. Sirt3 is the …